与WDR45相关的脑病变模仿与复合I缺陷相关的利氏综合征:一个病例报告
Giulia Ferrera1, Kevork Derderian2,3, Rossella Izzo4
1Child Neurology Unit - Department of Pediatric Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133, Milan, Italy.
European journal of human genetics : EJHG
|November 23, 2024
概括
致病性WDR45变体会导致神经发育障碍 (NDD). 这项研究将WDR45与线粒体功能障碍联系起来,特别是复杂I缺乏症,为BPAN病变产生提供了新的见解.
科学领域:
- 遗传学 是一个遗传学.
- 神经科学是一个神经科学.
- 线粒体生物学 线粒体生物学
背景情况:
- 致病性WDR45变体与神经发育障碍 (NDD) 有关,包括β-螺旋蛋白相关的神经退行 (BPAN).
- BPAN通常表现为发育迟缓,性衰竭和超金字塔症状.
- 线粒体疾病 (MDs) 可以模仿BPAN表型,使诊断复杂化.
研究的目的:
- 调查与WDR45相关的NDD的潜在机制,该NDD呈现Leigh类脑病变表型.
- 探索线粒体功能障碍在WDR45相关疾病中的潜在作用.
- 确定WDR45变体与呼吸链复杂缺陷之间的联系.
主要方法:
- 儿科患者的临床评估和神经成像 (MRI).
- 生物化学分析患者衍生肌肉和纤维细胞中呼吸链复合物的活性.
- 整体外基因组测序以识别致病变体.
- 自流量分析. 自流量分析.
主要成果:
- 该患者表现出智力障碍,心力衰竭和性,MRI发现表明利氏综合征,但没有脑铁积累.
- 观察到呼吸链复合物I (cI) 和复合物II (cII) 的活性降低.
- 外体测序发现了一种新的致病性WDR45变异.
- 这项研究是首次报告WDR45和受损CI组装和活动之间的联系.
结论:
- 线粒体功能障碍,特别是CI缺乏,是WDR45相关的NDD/BPAN的潜在病理生理机制.
- 与WDR45相关的NDD应在早期发病的NDD的差异诊断中考虑,特别是具有CI缺乏的利氏类脑病,即使没有脑铁.
- 这一发现扩大了对BPAN分子基础和诊断标准的理解.
相关概念视频
ATP Synthase: Structure
16.3K
ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
16.3K
Encephalitis l: Introduction
27
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
27
Encephalitis ll: Pathophysiology
30
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
30
Cerebral Edema ll: Pathophysiology
31
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this...
31
Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35
Hepatic Encephalopathy
71
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
71


